tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market

Atossa Therapeutics (ATOS) Income Statement

Compare
2,288 Followers

Atossa Therapeutics Income Statement

Last quarter (Q3 2024), Atossa Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Atossa Therapeutics's net income was $-7.23M. See Atossa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -23.00K$ -8.00K$ -23.00K$ -46.60K$ -52.79K
Operating Expenses
$ 31.38M$ 27.69M$ 20.52M$ 14.61M$ 17.27M
Depreciation and Amortization
$ 23.00K$ 8.00K$ 23.00K$ 46.60K$ 52.79K
EBITDA
$ -31.35M$ -27.68M$ -20.50M$ -14.56M$ -17.21M
Operating Income
$ -31.38M$ -27.69M$ -20.52M$ -14.61M$ -17.27M
Other Income/Expenses
$ 1.28M$ 731.00K$ -85.00K$ -3.22M$ 25.65K
Pretax Income
$ -30.09M$ -26.96M$ -20.61M$ -17.83M$ -17.24M
Net Income
$ -30.09M$ -26.23M$ -20.61M$ -21.10M$ -17.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.24$ -0.21$ -0.18$ -1.87$ -2.03
Diluted EPS
$ -0.24$ -0.21$ -0.18$ -1.87$ -2.03
Weighted Average Shares Outstanding
126.08M 126.62M 116.95M 11.31M 8.50M
Weighted Average Shares Outstanding (Diluted)
126.08M 126.62M 116.95M 11.31M 8.50M
Currency in USD

Atossa Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis